HilleVax, Inc. (HLVX) Tops Q2 EPS by 6c

HilleVax, Inc. (NASDAQ: HLVX) reported Q2 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on HilleVax, Inc. (HLVX) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Wolfe Research sees CNH stock flat 2027 outlook on commodity prices
• Is the global equity rally broadening? UBS weighs in